Jeff Yass’s AEON Biopharma AEON Stock Holding History

Jeff Yass’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-859	Closed	-$621K	–	12468
2022 Q4	$621K	Buy	859 +150	+21%	+$107K	﹤0.01%	7307
2022 Q3	$503K	Buy	+709	New	+$502K	﹤0.01%	8469

Other funds holding AEON

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Jeff Yass's AEON Position: Q1 2023 in Review

Jeff Yass sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 859 shares — an estimated $621K sold.

Jeff Yass first reported a position in AEON in Q3 2022 and held it in 2 quarters. The position peaked at $621K in Q4 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

Jeff Yass reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
Jeff Yass sold 859 AEON Biopharma shares in Q1 2023, an estimated $621K.
Jeff Yass first reported a position in AEON Biopharma in Q3 2022 and held it in 2 quarters.
Jeff Yass's AEON Biopharma position peaked at $621K in Q4 2022.
21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.